摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-[bis(2-hydroxyethyl)]-N-(triphenylmethyl)amine | 23202-47-3

中文名称
——
中文别名
——
英文名称
N,N-[bis(2-hydroxyethyl)]-N-(triphenylmethyl)amine
英文别名
2-[(2-hydroxy-ethyl)-trityl-amino]ethanol;N-trityldiethanolamine;N-trityl-N,N-diethanolamine;N-trityl-diethanolamine;N-Trityl-diaethanolamin;2-[2-hydroxyethyl(trityl)amino]ethanol
N,N-[bis(2-hydroxyethyl)]-N-(triphenylmethyl)amine化学式
CAS
23202-47-3
化学式
C23H25NO2
mdl
——
分子量
347.457
InChiKey
YJLPWJRMZCVURD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    160 °C(Solv: chloroform (67-66-3); ligroine (8032-32-4))
  • 沸点:
    494.8±40.0 °C(Predicted)
  • 密度:
    1.154±0.06 g/cm3(Predicted)
  • 溶解度:
    溶于DCM。乙酸乙酯、甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    26
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    43.7
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

点击查看最新优质反应信息

文献信息

  • Aliphatic amino bis-aryl squalene synthase inhibitors
    申请人:Rhone-Poulenc Rorer Pharmaceuticals Inc.
    公开号:US05455260A1
    公开(公告)日:1995-10-03
    This invention relates to a class of novel aliphatic amino bis-aryl compounds containing at least four carbon atoms and an amino group either substituted thereon or incorporated therein and is further linked or bridged to two mono- and/or bicyclic rings. Compounds of this invention reduce levels of serum cholesterol in the body without significantly reducing mevalonic metabolite synthesis. This invention relates also to pharmacological compositions and method of treatment for lowering serum cholesterol levels using the compounds of this invention.
    这项发明涉及一类新型的脂肪族氨基双芳基化合物,其中至少含有四个碳原子和一个氨基团,该氨基团可以被取代或者内含,并且进一步连接或者桥接到两个单环和/或双环环。这项发明的化合物在不显著降低麦角甾醇代谢产物合成的情况下,降低体内血清胆固醇水平。这项发明还涉及使用这些化合物降低血清胆固醇水平的药理组合物和治疗方法。
  • MELANIN PRODUCTION INHIBITOR
    申请人:Yokoyama Kouji
    公开号:US20110243865A1
    公开(公告)日:2011-10-06
    Disclosed is a melanin production inhibitor which has an excellent inhibitory activity on the production of melanin and is highly safe. The melanin production inhibitor comprises a compound represented by general formula (1) (excluding clotrimazole), and/or a pharmacologically acceptable salt thereof. In the formula, A1, A2 and A3 are independently selected from a hydrogen atom, an aryl group which may have a substituent, and an aromatic heterocyclic group which may have a substituent, wherein at least one of A1, A2 and A3 is selected from the aryl group and the aromatic heterocyclic group, the total number of carbon atoms contained in A1, A2 and A3 is 6 to 50 and, when at least two of A1, A2 and A3 represent the aryl groups or the aromatic heterocyclic groups, the adjacent two aryl or aromatic heterocyclic groups may be bound to each other via an alkyl chain or an alkenyl chain to form a ring; m represents an integer of 0 to 2; X represents a hetero atom, a hydrogen atom, or a carbon atom; R1 and R2 are independently selected from a hydrogen atom and an oxo group, wherein when one of R1 and R2 is an oxo group, the other is not present; and R3 is selected from a hydrogen atom, and a C 1-8 hydrocarbon group in which one or some of hydrogen atoms or carbon atoms may be substituted by a hetero atom or hetero atoms, wherein the number of R3's present in the compound corresponds to the number of X's and, when two or more R3's are present, the R3's are independently present and the adjacent two R3's may be bound to each other to form, together with X, a ring, and the terminal of R3 may be bound to a carbon atom to which A1, A2 and A3 are bound, thereby forming a ring.
    披露了一种黑色素生产抑制剂,它对黑色素的生产具有出色的抑制活性且高度安全。该黑色素生产抑制剂包括由通用公式(1)表示的化合物(不包括克霉唑)和/或其药理上可接受的盐。在公式中,A1、A2和A3独立地选自氢原子、可能带有取代基的芳基团和可能带有取代基的芳香杂环团,其中至少A1、A2和A3之一选自芳基团和芳香杂环团,A1、A2和A3中包含的碳原子总数为6至50,并且当至少两个A1、A2和A3表示芳基团或芳香杂环团时,相邻的两个芳基或芳香杂环团可以通过烷基链或烯基链相互连接形成环;m代表0至2的整数;X代表异原子、氢原子或碳原子;R1和R2独立地选自氢原子和氧代基,其中当R1和R2之一是氧代基时,另一个不出现;R3选自氢原子和C 1-8 碳氢化合物组,其中一些或所有的氢原子或碳原子可能被异原子或异原子取代,其中化合物中存在的R3的数量对应于X的数量,并且当存在两个或更多R3时,R3独立地存在,并且相邻的两个R3可以相互连接以与X一起形成环,并且R3的末端可以与A1、A2和A3连接的碳原子结合,从而形成环。
  • Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity
    申请人:Winchell S. Harry
    公开号:US20050112066A1
    公开(公告)日:2005-05-26
    Cyclic polyaza chelators that possess high affinity and specificity for first transition series metal cations exhibit an unanticipated improvement in biological activity when administered as complexes with cations of the alkaline earth metals, Ca(II) and Mg(II), most notably Ca(II). By virtue of this improvement, these complexes are particularly effective in the treatment of pathological conditions, including ischemia and ischemia-reperfusion injury.
    具有高亲和力和特异性的环状多氮螯合剂,当与碱土金属阳离子的络合物一起给药时,表现出生物活性的意外改善,其中以Ca(II)和Mg(II)的络合物最为显著,尤其是Ca(II)。由于这种改善,这些络合物在治疗病理条件,包括缺血和缺血再灌注损伤方面特别有效。
  • [EN] NOVEL SULFENAMIDES AND SULFENAMIDE OXIDES<br/>[FR] NOUVEAUX SULFÉNAMIDES ET OXYDES DE SULFÉNAMIDE
    申请人:UNIV GRIFFITH
    公开号:WO2006037185A1
    公开(公告)日:2006-04-13
    A compound of the general formula (I): wherein R1, R2, X1, X1', X2, X2', X3, X3', X4, X4' and X5 define various substituents and p is 0, 1 or 2. The invention also relates to use of the compounds as anti-microbial agents.
    通式(I)的化合物:其中R1、R2、X1、X1'、X2、X2'、X3、X3'、X4、X4'和X5定义了各种取代基,p为0、1或2。本发明还涉及将这些化合物用作抗微生物剂。
  • Synthesis of novel perfluoroalkyl nonionic surfactants with a bipodal hydrophilic moiety
    作者:Claude Selve、El Mostafa Moummi、Jean-Jacques Delpuech
    DOI:10.1039/c39870001437
    日期:——
    Monodisperse perfluoroalkyl N,N′-polyethoxylated amides, synthesized as dimethyl ether derivatives, CnF2n+ 1CH2C(O)N([C2H4O]mMe)2 are efficient bipodal nonionic fluorinated surfactants.
    作为二甲醚衍生物C n F 2 n +1 CH 2 C(O)N([C 2 H 4 O] m Me)2合成的单分散全氟烷基N,N'-聚乙氧基化酰胺是有效的两足非离子氟化表面活性剂。
查看更多

同类化合物

(3-三苯基甲氨基甲基)吡啶 非马沙坦杂质1 隐色甲紫-d6 隐色孔雀绿-d6 隐色孔雀绿 隐色乙基结晶紫 降钙素杂质10 酸性黄117 酸性蓝119 酚酞啉 酚酞二硫酸钾水合物 萘,1-甲氧基-3-甲基 苯酚,4-(1,1-二苯基丙基)- 苯甲醇,4-溴-a-(4-溴苯基)-a-苯基- 苯甲酸,4-(羟基二苯甲基)-,甲基酯 苯甲基N-[(2(三苯代甲基四唑-5-基-1,1联苯基-4-基]-甲基-2-氨基-3-甲基丁酸酯 苯基双-(对二乙氨基苯)甲烷 苯基二甲苯基甲烷 苯基二[2-甲基-4-(二乙基氨基)苯基]甲烷 苯基{二[4-(三氟甲基)苯基]}甲醇 苯基-二(2-羟基-5-氯苯基)甲烷 苄基2,3,4-三-O-苄基-6-O-三苯甲基-BETA-D-吡喃葡萄糖苷 苄基 5-氨基-5-脱氧-2,3-O-异亚丙基-6-O-三苯甲基呋喃己糖苷 苄基 2-乙酰氨基-2-脱氧-6-O-三苯基-甲基-alpha-D-吡喃葡萄糖苷 苄基 2,3-O-异亚丙基-6-三苯甲基-alpha-D-甘露呋喃糖 膦酸,1,2-乙二基二(磷羧基甲基)亚氨基-3,1-丙二基次氮基<三价氮基>二(亚甲基)四-,盐钠 脱氢奥美沙坦-2三苯甲基奥美沙坦脂 美托咪定杂质28 绿茶提取物茶多酚陕西龙孚 结晶紫 磷,三(4-甲氧苯基)甲基-,碘化 碱性蓝 硫代硫酸氢 S-[2-[(3,3,3-三苯基丙基)氨基]乙基]酯 盐酸三苯甲基肼 白孔雀石绿-d5 甲酮,(反-4-氨基-4-甲基环己基)-4-吗啉基- 甲基三苯基甲基醚 甲基6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷三苯甲酸酯 甲基3,4-O-异亚丙基-2-O-甲基-6-O-三苯甲基吡喃己糖苷 甲基2-甲基-N-{[4-(三氟甲基)苯基]氨基甲酰}丙氨酸酸酯 甲基2,3,4-三-O-苯甲酰基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-苄基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃半乳糖苷 甲基-6-O-三苯基甲基-alpha-D-吡喃葡萄糖苷 甲基(1-trityl-1H-imidazol-4-yl)乙酸酯 甲基 2,3,4-三-O-苄基-6-O-三苯基甲基-ALPHA-D-吡喃甘露糖苷 环丙胺,1-(1-甲基-1-丙烯-1-基)- 溶剂紫9 溴化N,N,N-三乙基-2-(三苯代甲基氧代)乙铵 海涛林